Company Filing History:
4 out of 378 
1 out of 12,164 
Years Active: 2020
Title: Marie-Pierre Collin-Kröpelin: Innovator in Pharmaceutical Chemistry
Introduction
Marie-Pierre Collin-Kröpelin is a distinguished inventor based in Wuppertal, Germany. She has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of novel compounds for medical applications. With a total of 4 patents to her name, her work has the potential to impact the treatment of various diseases.
Latest Patents
Among her latest patents is the invention titled "Amide-substituted phenyltriazole derivatives and uses thereof." This invention relates to novel 5-(carboxamide)-1-phenyl-1,2,4-triazole derivatives, processes for their preparation, and pharmaceutical compositions containing these compounds. The applications of these compounds are particularly focused on the treatment and prevention of renal and cardiovascular diseases. Another notable patent is the "Method for producing 5-hydroxyalkyl-substituted 1-phenyl-1,2,4-triazole derivatives," which describes an improved process for preparing these derivatives.
Career Highlights
Marie-Pierre has worked with prominent companies in the pharmaceutical industry, including Bayer Pharma Aktiengesellschaft and Bayer Aktiengesellschaft. Her experience in these organizations has allowed her to develop her expertise and contribute to innovative solutions in drug development.
Collaborations
Throughout her career, Marie-Pierre has collaborated with notable colleagues such as Thomas Neubauer and Heiko Schirmer. These collaborations have further enriched her research and development efforts.
Conclusion
Marie-Pierre Collin-Kröpelin is a remarkable inventor whose work in pharmaceutical chemistry continues to pave the way for advancements in medical treatments. Her innovative patents and collaborations highlight her significant contributions to the field.